Bethesda transfusion therapy company raises $2.7 million
December 20, 2017 at 14:42 PM EST
The company is focused on creating innovations in the transfusion medicine industry, including a device that removes oxygen from red blood cells.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|